Clinical Research Directory

Inclusion Criteria for Group A - Parent with Bipolar Disorder: 1. Age: 18 years or older. 2. Confirmation of a lifetime Bipolar I or II diagnosis 3. Parent status: Has at least one biological child aged 7-21 years. 4. Capacity and willingness to consent: Able and willing to provide informed consent. 5. Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments). 6. Language: Able to read, speak, and understand English. Inclusion Criteria for Group B - Adult Caregiver: 1. Age: 18 years or older. 2. Caregiver status: The adult primarily responsible for the daily care and/or medical decisions for ≥ 6 months for a child aged 7-21 years whose biological parent has a lifetime, clinician-confirmed diagnosis of Bipolar I or II disorder. 3. Capacity and willingness to consent: Able and willing to provide informed consent. 4. Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments). 5. Language: Able to read, speak, and understand English. Inclusion Criteria for Group C - At-Risk Youth: 1. Age: 1. Phase 1 (co-design) and Phase 2A (alpha testing): 13-18 years 2. Phase 2B (beta testing): 13-18 years 3. Phase 3 (screening): 7-21 years 2. Diagnosis status: Must not have a current diagnosis of Bipolar I or II disorder. 3. Parental diagnosis: Has at least 1 biological parent with a lifetime, clinician-confirmed Bipolar I or II diagnosis (as defined in Groups A and B). 4. Consent/Assent: 1. For youth aged 18-21: Able and willing to provide informed consent (verbal) 2. For youth aged 7-21: Parent/guardian/LAR able and willing to provide informed consent (verbal) and youth able to provide assent (verbal) 5. Participant ability: Able and willing to participate in study activities (e.g., co-design discussions, questionnaires, or screening assessments. 6. Language: English sufficient to comprehend study procedures and materials. Criteria for Exclusion of Participants A potential participant will NOT be eligible for participation in this study if any of the following criteria are met: 1. Unable to provide informed consent due to cognitive impairment or language barriers 2. Experiencing acute psychiatric instability at enrollment (e.g., acute psychosis or acute suicidality without stabilization) 3. Has a medical or psychiatric condition that, in the judgment of the Principal Investigator or study clinician, would place undue risk on the individual or interfere with standard clinical care